Pharmaceutical combination for the treatment of high blood pressure

摘要

The invention relates to pharmaceutical preparations which, as pharmacological active compounds, contain the hypotensive compound 4,5-dihydro-6-[4-(1H-imidazol-1-yl)-2-thienyl]-5-methyl-3(2H)-pyridazi none (motapizone) and a beta-receptor-blocking compound.